Cite
ATN cerebrospinal fluid biomarkers in dementia with Lewy bodies: Initial results from the United States Dementia with Lewy Bodies Consortium.
MLA
Jain, Lavanya, et al. “ATN Cerebrospinal Fluid Biomarkers in Dementia with Lewy Bodies: Initial Results from the United States Dementia with Lewy Bodies Consortium.” Alzheimer’s & Dementia : The Journal of the Alzheimer’s Association, vol. 20, no. 1, Jan. 2024, pp. 549–62. EBSCOhost, https://doi.org/10.1002/alz.13398.
APA
Jain, L., Khrestian, M., Formica, S., Tuason, E. D., Pillai, J. A., Rao, S., Oguh, O., Lippa, C. F., Lopez, O. L., Berman, S. B., Tsuang, D. W., Zabetian, C. P., Irwin, D. J., Galasko, D. R., Litvan, I., Marder, K. S., Honig, L. S., Fleisher, J. E., Galvin, J. E., … Bekris, L. M. (2024). ATN cerebrospinal fluid biomarkers in dementia with Lewy bodies: Initial results from the United States Dementia with Lewy Bodies Consortium. Alzheimer’s & Dementia : The Journal of the Alzheimer’s Association, 20(1), 549–562. https://doi.org/10.1002/alz.13398
Chicago
Jain, Lavanya, Maria Khrestian, Shane Formica, Elizabeth D Tuason, Jagan A Pillai, Stephen Rao, Odinachi Oguh, et al. 2024. “ATN Cerebrospinal Fluid Biomarkers in Dementia with Lewy Bodies: Initial Results from the United States Dementia with Lewy Bodies Consortium.” Alzheimer’s & Dementia : The Journal of the Alzheimer’s Association 20 (1): 549–62. doi:10.1002/alz.13398.